Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo

[1]  W. Muller,et al.  Focal adhesion kinase contributes to proliferative potential of ErbB2 mammary tumour cells but is dispensable for ErbB2 mammary tumour induction in vivo , 2012, Breast Cancer Research.

[2]  W. Muller,et al.  Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis , 2011, Proceedings of the National Academy of Sciences.

[3]  J. Guan,et al.  Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity* , 2011, The Journal of Biological Chemistry.

[4]  G. Forni,et al.  p130Cas is an essential transducer element in ErbB2 transformation , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  W. Muller,et al.  β1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression , 2010, Proceedings of the National Academy of Sciences.

[6]  G. Mills,et al.  Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer , 2010, Oncogene.

[7]  G. Mcmahon,et al.  Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models , 2010, Cancer biology & therapy.

[8]  G. Mcmahon,et al.  PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments , 2010, Cancer biology & therapy.

[9]  H. Frierson,et al.  Differential requirement for focal adhesion kinase signaling in cancer progression in the transgenic adenocarcinoma of mouse prostate model , 2009, Molecular Cancer Therapeutics.

[10]  W. Gerald,et al.  Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. , 2009, The Journal of clinical investigation.

[11]  M. Wicha,et al.  Mammary epithelial-specific ablation of the focal adhesion kinase suppresses mammary tumorigenesis by affecting mammary cancer stem/progenitor cells. , 2009, Cancer research.

[12]  Paolo P. Provenzano,et al.  Tumorigenesis and Neoplastic Progression Mammary Epithelial-Specific Disruption of Focal Adhesion Kinase Retards Tumor Formation and Metastasis in a Transgenic Mouse Model of Human Breast Cancer , 2008 .

[13]  T. Bismar,et al.  Tumorigenesis and Neoplastic Progression Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness , 2010 .

[14]  D. Haber,et al.  Modeling oncogene addiction using RNA interference , 2008, Proceedings of the National Academy of Sciences.

[15]  J. Guan,et al.  Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK , 2008, The Journal of cell biology.

[16]  T. Pawson,et al.  ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.

[17]  Matthew D. Wessel,et al.  Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. , 2008, Cancer research.

[18]  R. Cardiff,et al.  Mammary epithelial-specific disruption of the focal adhesion kinase blocks mammary tumor progression , 2007, Proceedings of the National Academy of Sciences.

[19]  D. Schlaepfer,et al.  FAK signaling is critical for ErbB-2/ErbB-3 receptor cooperation for oncogenic transformation and invasion , 2005, The Journal of cell biology.

[20]  Joseph Geradts,et al.  High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype , 2005, Modern Pathology.

[21]  R. Kimmig,et al.  High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome , 2005, Breast Cancer Research.

[22]  S. Grant,et al.  Specific deletion of focal adhesion kinase suppresses tumor formation and blocks malignant progression. , 2004, Genes & development.

[23]  C. Livasy,et al.  Upregulation of focal adhesion kinase (FAK) expression in ductal carcinoma in situ (DCIS) is an early event in breast tumorigenesis , 2004, Breast Cancer Research and Treatment.

[24]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[25]  G. Nemerow,et al.  Differential regulation of cell motility and invasion by FAK , 2003, The Journal of cell biology.

[26]  L. Koss,et al.  Focal adhesion kinase as a marker of malignant phenotype in breast and cervical carcinomas. , 2003, Human pathology.

[27]  E. Ruoslahti,et al.  Decreased focal adhesion kinase suppresses papilloma formation during experimental mouse skin carcinogenesis. , 2001, Cancer research.

[28]  D. Brenner,et al.  The Focal Adhesion Kinase Suppresses Transformation-associated, Anchorage-independent Apoptosis in Human Breast Cancer Cells , 2000, The Journal of Biological Chemistry.

[29]  C. Smart,et al.  The Proliferative and Migratory Activities of Breast Cancer Cells Can Be Differentially Regulated by Heparan Sulfates* , 2000, The Journal of Biological Chemistry.

[30]  M. Rudnicki,et al.  Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Ethier,et al.  ERBB-2 overexpression confers PI 3 ′ kinase-dependent invasion capacity on human mammary epithelial cells , 2000, British Journal of Cancer.

[32]  R. Cardiff,et al.  Elevated expression of activated forms of Neu/ErbB‐2 and ErbB‐3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer , 1999, The EMBO journal.

[33]  Philippe Soriano Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.